View in EDS PDF Full Text

Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24.

Saved in:
Bibliographic Details
Title: Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24.
Authors: Bar J; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada. Electronic address: bar.jair@gmail.com., Ding K; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada., Zhao H; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Han L; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada., Laurie SA; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada., Seymour L; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada., Addison CL; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Faculty of Medicine and the Department of Biochemistry at the University of Ottawa, Ottawa, Ontario, Canada., Shepherd FA; University Health Network, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Goss GD; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada., Dimitroulakos J; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Faculty of Medicine and the Department of Biochemistry at the University of Ottawa, Ottawa, Ontario, Canada., Bradbury PA; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada.
Source: Clinical lung cancer [Clin Lung Cancer] 2015 Nov; Vol. 16 (6), pp. e189-201. Date of Electronic Publication: 2015 May 13.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26081815
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bar+J%22">Bar J</searchLink>; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada. Electronic address: bar.jair@gmail.com.<br /><searchLink fieldCode="AU" term="%22Ding+K%22">Ding K</searchLink>; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Zhao+H%22">Zhao H</searchLink>; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Han+L%22">Han L</searchLink>; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Laurie+SA%22">Laurie SA</searchLink>; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Seymour+L%22">Seymour L</searchLink>; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Addison+CL%22">Addison CL</searchLink>; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Faculty of Medicine and the Department of Biochemistry at the University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Shepherd+FA%22">Shepherd FA</searchLink>; University Health Network, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Goss+GD%22">Goss GD</searchLink>; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Dimitroulakos+J%22">Dimitroulakos J</searchLink>; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Faculty of Medicine and the Department of Biochemistry at the University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Bradbury+PA%22">Bradbury PA</searchLink>; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2015 Nov; Vol. 16 (6), pp. e189-201. <i>Date of Electronic Publication: </i>2015 May 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26081815
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cllc.2015.05.002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e189
    Titles:
      – TitleFull: Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bar J
      – PersonEntity:
          Name:
            NameFull: Ding K
      – PersonEntity:
          Name:
            NameFull: Zhao H
      – PersonEntity:
          Name:
            NameFull: Han L
      – PersonEntity:
          Name:
            NameFull: Laurie SA
      – PersonEntity:
          Name:
            NameFull: Seymour L
      – PersonEntity:
          Name:
            NameFull: Addison CL
      – PersonEntity:
          Name:
            NameFull: Shepherd FA
      – PersonEntity:
          Name:
            NameFull: Goss GD
      – PersonEntity:
          Name:
            NameFull: Dimitroulakos J
      – PersonEntity:
          Name:
            NameFull: Bradbury PA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2015 Nov
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0690
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical lung cancer
              Type: main
ResultId 1